NYSE · LLY
Eli Lilly and Company
$1,419.50+$45.80 (+3.33%)
Eli Lilly and Company’s quoted price is above the reported 52-week high. The range and quote may have different update times.
Loading market information…
NASDAQ · CMAX · USD
Stock price, earnings
Quote as of Mar 9, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
CareMax, Inc.’s quoted price sits in the lower half of its reported 52-week range, 18.94% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow CareMax, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
CareMax, Inc. delivers a broad spectrum of medical services to patients, facilitated by its network of physicians and healthcare professionals. The company offers a comprehensive array of medical and social support programs, which includes general practice, specialized treatments, remote healthcare consultations, wellness initiatives, vision care, dental services, prescription fulfillment, and transportation assistance. Additionally, CareMax provides CareOptimize, a proprietary software and services platform that equips physicians across the United States with essential data, analytical tools, and structured decision-making workflows. As of December 31, 2021, the company managed 48 diverse medical centers situated in Florida, Tennessee, and New York. CareMax, Inc.'s main corporate office is located in Miami, Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:31 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q4 2022 | Mar 30, 2023 | $3.10+258.04% vs estimate | $164.26M+9.73% vs estimate |
|---|
| Q4 2022 | Mar 9, 2023 | -$0.16-220.0% vs estimate | $164.26M+9.73% vs estimate |
|---|
THE ANALYST VIEW
5 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1,419.50+$45.80 (+3.33%)
Eli Lilly and Company’s quoted price is above the reported 52-week high. The range and quote may have different update times.
$276.34+$1.14 (+0.41%)
Johnson & Johnson’s quoted price sits in the upper half of its reported 52-week range, 1.68% below the high.
$0.60-$0.10 (-14.27%)
ASLAN Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 96.48% below the high.
$0.53-$0.17 (-24.12%)
Oncternal Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.04% below the high.
$0.47-$0.12 (-20.74%)
Avinger, Inc.’s quoted price sits in the lower half of its reported 52-week range, 89.15% below the high.
$2.20+$0.17 (+8.37%)
NAYA Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 87.09% below the high.
$0.38-$0.01 (-1.56%)
NeuBase Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.49% below the high.
$0.00$0.00 (0.0%)
G Medical Innovations Holdings Ltd’s quoted price sits in the lower half of its reported 52-week range, 99.6% below the high.
